Drug recall · January 28, 2026
Furosemide Tablets recall
Why: Presence of Foreign Substance
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
- Lots / codes
Lot# FUB125042G; Exp. 05/13/2027
- Quantity
- 4212 bottles
- Company
- Graviti Pharmaceuticals Private Limited, Hyderabad
- Distribution
- U.S. Nationwide
- Initiated
- January 10, 2026 · Voluntary: Firm initiated
- Classified
- January 21, 2026
- Reported
- January 28, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Furosemide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.